For the Inventor, By the Inventor

Enter assignee name

Zhejiang, China

Tyk Medicines Inc.

USPTO Granted Patents = 5

EPO Patents = 4

Forward Citations = 0

Loading Chart...

Loading Chart...

7 inventors (with patents filed for the assignee):

Yusheng Wu (5 out of 5 patents)

Apeng Liang (5 out of 5 patents)

Chengshan Niu (5 out of 5 patents)

4. Jun Li (4 out of 20 patents)

5. Maolin Zheng (2 out of 2 patents)

6. Yang Geng (1 out of 1 patent)

7. Zhongwei Guo (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 12629358 - Compound used as RET kinase inhibitor and application thereof (2026-05-19),

2. 12545681 - Compound used as RET kinase inhibitor and application thereof (2026-02-10),

3. 12509441 - Compounds used as kinase inhibitors and application thereof (2025-12-30),

4. 12435089 - 3-oxadiazolyl substituted pyrazolo[1,5,a]pyrimidines for ROS1, NTRK, and ALK mediated diseases (2025-10-07),

5. 10882845 - Crystal form of deuterated AZD9291, preparation method therefor, and use thereof (2021-01-05),

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

5 Patents

#131 in Zhejiang

#5,228 in China

Zhejiang, China

Tyk Medicines Inc.

Forward Citations = 0

7 inventors:

Yusheng Wu (5 out of 5 patents)

Apeng Liang (5 out of 5 patents)

Chengshan Niu (5 out of 5 patents)

4. Jun Li (4 out of 20 patents)

5. Maolin Zheng (2 out of 2 patents)

Please report any incorrect information to [email protected]

Loading…